Principal Scientist
United States Pharmacopeia, Maryland
Ben Clarke develops USP physical reference standards for biologics and ensures their consistent quality and suitability for use. It is his pleasure to work with laboratories across the world to rigorously test USP reference standards and develop new compendial methods. He is the scientific lead for USP’s cell and gene therapy expert volunteers, who are partners in developing standards and quality solutions for advanced therapies.
Before joining USP, Ben developed potency bioassays for mRNA and RSV vaccines at GSK. His post-doctoral research at the NIH included developing mouse models using CRISPR/Cas9 genome editing. He received his Ph.D. in Cell Biology from Cornell University and his B.S. in Biochemistry from the Pennsylvania State University.
Disclosure information not submitted.
Advancing AAV Standards in Gene Therapy
Tuesday, November 11, 2025
10:30 AM - 11:00 AM CT